Click on image to view larger version.

Figure 2 Effects of 12-month carvedilol (n = 14, black bars) or metoprolol (n = 16, open bars) treatment on left ventricular (LV) remodeling in dilated cardiomyopathy patients with persistent LV dysfunction despite chronic optimum treatment including angiotensin-converting enzyme inhibitors and metoprolol. *p = 0.053, 12 months carvedilol vs. metoprolol; p = 0.047, 12 months carvedilol vs. metoprolol. LVEDV = LV end-diastolic volume; LVESV = LV end-systolic volume.